PRKACA's downstream effects involve multiple pathways, including WNT signaling, a pathway directly related with cPLA2ɑ signaling (Xu et al., 2019), and psoriasis in general (Gudjonsson et al., 2010). Here, PLA2G4A is linked to psoriasis.